(2-Methylbenzo[d]oxazol-6-yl)boronic acid

Catalog No. :
ACXTBN651
CAS No. :
866332-15-2
Molecular Formula :
C8H8BNO3
Molecular Weight :
176.97

IUPAC Name:(2-methylbenzo[d]oxazol-6-yl)boronic acid

(2-Methylbenzo[d]oxazol-6-yl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$124.00Login to see priceIn stockInquiry
5g98%$476.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2-Methylbenzo[d]oxazol-6-yl)boronic acid
IUPAC Name(2-methylbenzo[d]oxazol-6-yl)boronic acid
MDL No.MFCD10697425
Molecular FormulaC8H8BNO3
Molecular Weight176.97
SMILESCC1=NC2=CC=C(B(O)O)C=C2O1
InChI KeyMFPJERIVTFQLEG-UHFFFAOYSA-N
Synonym2-methyl-benzoxazol-6-boronic acid | 2-methylbenzo[d]oxazol-6-ylboronic acid | AC7015 | SCHEMBL15738098 | DTXSID10717031 | MFCD10697425 | SY130001 | (2-Methylbenzo[d]oxazol-6-yl)boronic acid | 2-Methylbenzo[d]oxazole-6-boronic acid | AKOS006302503 | 2-Met
CAS No.866332-15-2
PubChem CID55262500

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P233-P260-P261-P264-P270-P271-P280-P301+P312-P302+P352-P304-P304+P340-P305+P351+P338-P312-P321-P330-P332+P313-P337+P313-P340-P362-P403-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACXTBN651 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXTBN651 route product structure diagram
    ACXTBN651866332-15-2 In Stock
Inquiry

2. ACXTBN651 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPCIM905 route compound structure diagram
    ACPCIM905151230-42-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXTBN651 route product structure diagram
    ACXTBN651866332-15-2 In Stock
Inquiry

Comments (0)